Patents by Inventor Louis William Licamele

Louis William Licamele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CANCER TREATMENT
    Publication number: 20210324093
    Abstract: The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele, Christian Lavedan
  • METHOD OF TREATMENT
    Publication number: 20210299080
    Abstract: Embodiments of the invention relate generally to increasing adult height in individuals with no light perception (NLP).
    Type: Application
    Filed: April 13, 2021
    Publication date: September 30, 2021
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 11090285
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: August 17, 2021
    Assignee: VANDA PHARMACEUTICALS INC
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Cancer treatment
    Patent number: 11078289
    Abstract: The invention relates generally to the treatment of cancer. One embodiment of the invention provides a method of treating cancer in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: August 3, 2021
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele, Christian Lavedan
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20210205261
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: March 19, 2021
    Publication date: July 8, 2021
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20210161854
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: February 8, 2021
    Publication date: June 3, 2021
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • Method of treatment
    Patent number: 11013713
    Abstract: Embodiments of the invention relate generally to increasing adult height in individuals with no light perception (NLP).
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: May 25, 2021
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20210128517
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 6, 2021
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 10980770
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: February 16, 2020
    Date of Patent: April 20, 2021
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 10945988
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: September 14, 2019
    Date of Patent: March 16, 2021
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • METHOD OF TREATMENT WITH TRADIPITANT
    Publication number: 20200360358
    Abstract: This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pruritus with tradipitant.
    Type: Application
    Filed: July 31, 2020
    Publication date: November 19, 2020
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele
  • Method of treatment with tradipitant
    Patent number: 10772880
    Abstract: This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pruritus with tradipitant.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: September 15, 2020
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20200179326
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: February 16, 2020
    Publication date: June 11, 2020
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • Treatment of circadian rhythm disorders
    Patent number: 10610510
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: April 7, 2020
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Marlene Michelle Dressman, John Joseph Feeney, Louis William Licamele, Mihael H. Polymeropoulos
  • MULTIPLE MYELOMA TREATMENT
    Publication number: 20200009087
    Abstract: The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
    Type: Application
    Filed: August 26, 2019
    Publication date: January 9, 2020
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele, Christian Lavedan
  • TREATMENT OF CIRCADIAN RHYTHM DISORDERS
    Publication number: 20200009106
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Application
    Filed: September 14, 2019
    Publication date: January 9, 2020
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • Method of treatment with tradipitant
    Patent number: 10463655
    Abstract: This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pruritus with tradipitant.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: November 5, 2019
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele
  • Treatment of circadian rhythm disorders
    Patent number: 10449176
    Abstract: Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
    Type: Grant
    Filed: November 26, 2017
    Date of Patent: October 22, 2019
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Marlene Michelle Dressman, Louis William Licamele, Mihael H. Polymeropoulos
  • METHOD OF TREATMENT WITH TRADIPITANT
    Publication number: 20190290626
    Abstract: This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pruritus with tradipitant.
    Type: Application
    Filed: June 4, 2019
    Publication date: September 26, 2019
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele
  • METHOD OF TREATMENT WITH TRADIPITANT
    Publication number: 20190290625
    Abstract: This application relates to a method of treatment with tradipitant, and more particularly, to a method of treatment of pruritus with tradipitant.
    Type: Application
    Filed: June 4, 2019
    Publication date: September 26, 2019
    Inventors: Mihael H. Polymeropoulos, Louis William Licamele